BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 6, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Feb. 3, 2005
View Archived Issues
Nuvelo Stock Offer: $63.75M For Alfimeprase, Other Drugs
Proving its financial mettle even without the hoped-for larger alfimeprase deal with Amgen Inc., Nuvelo Inc. priced an offering of 8.5 million shares at $7.50 each to pull down $63.75 million. (BioWorld Today)
Read More
Kyorin Pays $21M For ActivX To Be U.S.-Based Research Center
Read More
Tweaking Receptor Balancing Act To Reverse Autoimmunity
Read More
MEND Act Unveiled As Approach For Better Medicare Buying Power
Read More
FDA Approves Nascobal After Manufacturing Issues Solved
Read More
Other News To Note
Read More
Appointments And Advancements
Read More
